According to Longeveron's latest financial reports the company has a price-to-book ratio of 1.21.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 5.07 | 53.45% |
2022-12-31 | 3.30 | -50.88% |
2021-12-31 | 6.72 | |
2020-12-31 | N/A | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.71 | 124.15% | ๐บ๐ธ USA |